Skip to main content
. 2012 Jul 12;18(1):1197–1208. doi: 10.2119/molmed.2012.00075

Table 2.

Tumorigenicity of ES-2 cells at subcutaneous injection site.

Tumors incidence/number of injections

Group (0.75–1) × 105 1 × 104 1 × 103 1 × 102
Cultured SP 4/5 4/5 3/5 3/5
Cultured non-SP 5/5 5/5 3/5 0/5
Nonselected 5/5 5/5 3/5 1/5